Sex differences in the natural history of HIV infection may vary between resource-rich and resource-limited settings.
Methods
Baseline characteristics from a randomized clinical trial of treatment-naive subjects conducted at sites in Africa, Asia, the Caribbean, and North and South America were analysed to determine if there were significant differences by sex.
Results
Of the 1,571 participants, 740 (47.1%) were women. Women had higher mean screening CD4+ T-cell counts (mean 15 cells higher; P<0.001), lower mean haemoglobin and creatinine clearance, a lower mean baseline HIV-1 viral load (4.85 log10 versus 5.05 log10 copies/ml; P<0.001) and were less likely to have a prior AIDS diagnosis than men. The sex difference in viral load was related to CD4+ T-cell count; however, it was independent of country and persisted within the strata with CD4+ T-cell count <200 cells/mm3.
Conclusions
Women in resource-limited settings have lower levels of plasma HIV-1 RNA and appear to present for enrolment into clinical trials at an earlier stage of disease than men. The biological basis for lower viral load in women compared to men remains unexplained. It will be important to determine if the sex differences observed at baseline impact clinical outcomes once the PEARLS clinical trial is completed.
References
1.
Joint United Nations Programme on HIV/AIDS, World Health Organization.AIDS epidemic update: December 2009.Geneva: UNAIDS/WHO2009.
2.
FarzadeganH., HooverD.R., AstemborskiJ.Sex differences in HIV-1 viral load and progression to AIDS. Lancet1998; 352: 1510–1514.
3.
GandhiM., BacchettiP., MiottiP.Does patient sex affect human immunodeficiency virus levels?Clin Infect Dis2002; 35: 313–322.
4.
RezzaG., LepriA.C., D'Arminio MonforteA.Plasma viral load concentrations in women and men from different exposure categories and with known duration of HIV infection. ICONA Study Group. J Acquir Immune Defic Syndr2000; 25: 56–62.
5.
MooreA.L., KirkO., JohnsonA.M.Virologic, immunologic, and clinical response to highly active antiretroviral therapy: the gender issue revisited. J Acquir Immune Defic Syndr2003; 32: 452–461.
6.
TrichavarojR., de SouzaM.S., BuapunthP.HIV viral load in Thai men and women with subtype E infections. J Acquir Immune Defic Syndr2001; 26: 345–347.
7.
SterlingT.R., VlahovD., AstemborskiJ.Initial plasma HIV-1 RNA levels and progression to AIDS in women and men. N Engl J Med2001; 344: 720–725.
8.
PrinsM., MeyerL., HessolN.A.Sex and the course of HIV infection in the pre- and highly active antiretroviral therapy eras. AIDS2005; 19: 357–370.
9.
TouloumiG., PantazisN., BabikerA.G.CASCADE Collaboration differences in HIV RNA levels before the initiation of antiretroviral therapy among 1864 individuals with known HIV-1 seroconversion dates. AIDS2004; 18: 1697–1705.
10.
NapravnikS., PooleC., ThomasJ.C.Gender difference in HIV RNA levels: a meta-analysis of published studies. J Acquir Immune Defic Syndr2002; 31: 11–19.
11.
SterlingT.R., LylesC.M., VlahovD.Sex differences in longitudinal human immunodeficiency virus type 1 RNA levels among seroconverters. J Infect Dis1999; 180: 666–672.
12.
ShankerG., Sorci-ThomasM., AdamsM.R.Estrogen modulates the expression of tumor necrosis factor alpha mRNA in phorbol ester-stimulated human monocytic THP-1 cells. Lymphokine Cytokine Res1994; 13: 377–382.
13.
MellorsJ.W., GriffithB.P., OrtizM.A.Tumor necrosis factoralpha/cachectin enhances human immunodeficiency virus type 1 replication in primary macrophages. J Infect Dis1991; 163: 78–82.
14.
ReichelderferP.S., CoombsR.W., WrightD.J.Effect of menstrual cycle on HIV-1 levels in the peripheral blood and genital tract. WHS 001 Study Team. AIDS2000; 14: 2101–2107.
15.
PittJ., MoyeJ., MatthewsY.Sex differences in immunologic and virologic markers in children born to women infected by human immunodeficiency virus (HIV).8th Conference on Retroviruses and Opportunistic Infections. 4–8 February 2001, Chicago, IL, USA. Abstract 513.
16.
RhodesK., ScottA., MarkhanR.L.Immunological sex differences. Ann Rheum Dis1969; 28: 104–120.
17.
SterlingT.R., Pisell-NolandT., PerezJ.L.Sex-based differences in T lymphocyte responses in HIV-1-seropositive individuals. J Infect Dis2005; 191: 881–885.
18.
PortalesP., ClotJ., CorbeauP.Sex differences in HIV-1 viral load due to sex difference in CCR5 expression. Ann Intern Med2001; 134: 81–82.
19.
OvertonE.T., NurutdinovaD., FreemanJ.Factors associated with renal dysfunction within an urban HIV-infected cohort in the era of highly active antiretroviral therapy. HIV Med2009; 10: 343–350.
20.
LucasG.M., LauB., AttaM.G.Chronic kidney disease incidence and progression to end-stage renal disease in HIV-infected individuals: a tale of two races. J Infect Dis2008; 197: 1548–1557.
21.
DétiE.K., ThiébautR., BonnetF.Prevalence and factors associated with renal impairment in HIV-infected patients. HIV Med2010; 11: 308–317.
22.
TordatoF., Cozzi LepriA., CicconiP.Evaluation of glomerular filtration rate in HIV-1-infected patients before and after combined antiretroviral therapy exposure. HIV Med2011; 12: 4–13.
